DXR Daxor Corporation - Closed End Fund

NASDAQ · Health Care · View on SEC EDGAR ↗
$10.40
Price · Aug 14, 2026
Fundamentals as of Mar 28, 2012
52W Range
$9–$15
30% of range
Analyst Rating
BUY
6 analysts
Price Target
$22
+116% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

DXR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$10.40
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$9 – $15

DXR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
2-point trend, -8.4%
2010-12-31 → 2011-12-31
EPS —
Free Cash Flow —
2011-12-31 → 2011-12-31
Margins —
2011-12-31 → 2011-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
DXR
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
DXR
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
DXR
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
DXR
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
DXR
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
DXR
Peer Median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield
—
Payout Ratio
—
5Y Div CAGR
—
Ex-dateAmount
Jan. 5, 2018$0.0300
Dec. 20, 2016$0.0300
Dec. 18, 2015$0.0400
Dec. 4, 2014$0.0300
Dec. 5, 2013$0.0500
Dec. 7, 2012$0.1000
Aug. 10, 2012$0.1000
Nov. 16, 2011$0.1000
May 27, 2011$0.1500
Dec. 14, 2010$0.6500
Sept. 13, 2010$0.2500
May 27, 2010$0.1000
Dec. 8, 2009$1.0000
Aug. 21, 2009$0.2500
May 27, 2009$0.1000
Dec. 10, 2008$1.0000
Oct. 31, 2008$0.2500
July 24, 2008$0.2500
April 28, 1998$0.1250
April 28, 1997$0.5000

DXR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 6 analysts
  • Strong Buy 1 16.7%
  • Buy 4 66.7%
  • Hold 1 16.7%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

2 analysts · 2026-08-18
Median target $22.50 +116.3%
Mean target $22.50 +116.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.32%
Period EPS Actual EPS Est Surprise
Sept. 30, 2007 $0.43 $0.10 0.33%
June 30, 2007 $0.51 $0.01 0.50%
March 31, 2007 $0.66 $-0.03 0.69%
Dec. 31, 2006 $0.01 $-0.02 0.03%
March 31, 2006 $0.01 $-0.02 0.03%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
DXR — — — — — —
VANI $94M -2.9 — — -257.8% —
CVRX $187M -3.5 10.4% -94.1% -109.6% 85.3%
ODYS $54M -3.1 -23.9% -565.0% -58.7% 28.9%
COCH — — — — — —
MDAI — — — — — —
SRTS $66M -8.5 -34.3% -28.1% -15.4% 43.2%
POCI — -5.8 -0.07% — — —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 11
Annual Income Statement data for DXR
Metric Trend 20112010
Revenue 2-point trend, -8.4% $1M $2M
Cost of Revenue 2-point trend, -10.3% $652.5K $727.6K
Gross Profit 2-point trend, -6.8% $793.8K $851.6K
R&D Expense 2-point trend, -11.0% $3M $3M
SG&A Expense 2-point trend, +11.7% $4M $3M
Operating Expenses 2-point trend, +1.1% $7M $7M
Operating Income 2-point trend, -2.2% $-6M $-6M
Other Non-op 2-point trend, -173.9% $-168.9K $-61.7K
Income Tax 2-point trend, -252.0% $-5M $3M
Net Income 2-point trend, -244.6% $-7M $5M
EBITDA $-6M ·
Balance Sheet 20
Annual Balance Sheet data for DXR
Metric Trend 20112010
Cash & Equivalents 2-point trend, +3.3% $59.6K $57.7K
Short-term Investments 2-point trend, +3.6% $56M $54M
Receivables 2-point trend, +22.9% $219.7K $178.8K
Inventory 2-point trend, -17.1% $301.5K $363.6K
Prepaid Expense 2-point trend, +60.3% $209.3K $130.6K
Current Assets 2-point trend, -6.1% $82M $87M
PP&E (Net) 2-point trend, -4.0% $4M $4M
Other Non-current Assets Flat — no change across 2 periods $37.2K $37.2K
Total Assets 2-point trend, -6.0% $86M $91M
Accounts Payable 2-point trend, +20.3% $525.2K $436.5K
Current Liabilities 2-point trend, +12.2% $49M $44M
Total Liabilities 2-point trend, +12.0% $50M $44M
Common Stock Flat — no change across 2 periods $53.2K $53.2K
Paid-in Capital 2-point trend, +0.1% $11M $11M
Retained Earnings 2-point trend, -25.0% $25M $33M
Treasury Stock 2-point trend, +2.0% $12M $12M
AOCI 2-point trend, -15.6% $13M $15M
Stockholders' Equity 2-point trend, -22.9% $36M $47M
Liabilities + Equity 2-point trend, -6.0% $86M $91M
Shares Outstanding 2-point trend, -0.6% 4,202,351 4,226,137
Cash Flow 10
Annual Cash Flow data for DXR
Metric Trend 20112010
Stock-based Comp $9.7K ·
Deferred Tax 2-point trend, +106.1% $1M $606.4K
Operating Cash Flow 2-point trend, -14.4% $-7M $-6M
CapEx 2-point trend, -62.1% $123.2K $324.7K
Investing Cash Flow 2-point trend, -221.1% $-11M $9M
Dividends Paid 2-point trend, -75.1% $1M $4M
Financing Cash Flow 2-point trend, +555.3% $18M $-4M
Net Change in Cash 2-point trend, +100.9% $1.9K $-219.3K
Taxes Paid 2-point trend, +23.8% $3M $2M
Free Cash Flow $-7M ·
Profitability 6
Annual Profitability data for DXR
Metric Trend 20112010
Gross Margin 54.9% ·
Operating Margin -400.1% ·
Net Margin -496.8% ·
EBITDA Margin -400.1% ·
ROA -8.1% ·
ROE -17.3% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for DXR
Metric Trend 20112010
Current Ratio 1.7 ·
Quick Ratio 1.1 ·
Efficiency 3
Annual Efficiency data for DXR
Metric Trend 20112010
Asset Turnover 0.0 ·
Inventory Turnover 2.0 ·
Receivables Turnover 7.3 ·
Per Share 3
Annual Per Share data for DXR
Metric Trend 20112010
Book Value / Share $8.62 ·
Cash / Share $0.01 ·
Dividend Paid / Share 2-point trend, -75.0% $0 $1
Valuation (TTM) 10
Annual Valuation (TTM) data for DXR
Metric Trend 20112010
Revenue TTM 2-point trend, -8.4% $1M $2M
Net Income TTM 2-point trend, -244.6% $-7M $5M
Market Cap $38M ·
P/S 26.4 ·
P/B 1.1 ·
P / Cash Flow -5.9 ·
P / FCF -5.8 ·
Dividend Yield 2.8% ·
Payout Ratio -14.7% ·
Annual Payout 2-point trend, -75.1% $1M $4M

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2011-12-312010-12-31
Revenue $1M$2M
Gross Margin % 54.9%—
Operating Margin % -400.1%—
Net Income $-7M$5M
Balance Sheet
2011-12-312010-12-31
Current Ratio 1.7—
Quick Ratio 1.1—
Cash Flow
2011-12-312010-12-31
Free Cash Flow $-7M—

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 16 filers · $2.6M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
3 (-3 vs prior Q) 1 (0 vs prior Q) 7 (+7 vs prior Q) 1 (-2 vs prior Q) +51K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $707,705 47,980 27.70% Shares
VANGUARD CAPITAL MANAGEMENT LLC $495,635 48,831 19.40% Shares
Aristides Capital LLC $429,180 41,689 16.80% Shares
RENAISSANCE TECHNOLOGIES LLC $302,883 29,421 11.86% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $275,380 27,131 10.78% Shares
NANO CAP NEW MILLENNIUM GROWTH FUND L P $128,685 12,500 5.04% Shares
Crescent Grove Advisors, LLC $127,892 12,423 5.01% Shares
SBI Securities Co., Ltd. $32,233 3,131 1.26% Shares
MORGAN STANLEY $31,780 3,087 1.24% Shares
VANGUARD FIDUCIARY TRUST CO $10,526 1,037 0.41% Shares
OSAIC HOLDINGS, INC. $5,145 500 0.20% Shares
Tower Research Capital LLC (TRC) $3,140 305 0.12% Shares
THOMPSON SIEGEL & WALMSLEY LLC $2,489 241,767 0.10% Shares
UBS Group AG $1,771 172 0.07% Shares
JPMORGAN CHASE & CO $61 6 0.00% Shares
WELLS FARGO & COMPANY/MN $2 0 0.00% Shares

Company insiders 19 insiders · 7 officers · 14 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Michael Richard Feldschuh Chief Executive Officer June 23, 2026 A 243,694 0 0 $0
Robert J Michel Chief Financial Officer June 23, 2026 A 33,050 0 0 $0
Gary Joseph Fischman President Dec. 1, 2004 X — 0 0 $0
Jonathan Adam Feldschuh Chief Scientific Officer June 23, 2026 A 78,908 0 0 $0
Joseph Feldschuh Chairman April 17, 2016 S 2,838,482 0 0 $0
Diane Marie Meegan Corporate Secretary April 10, 2015 S 500 0 0 $0
Everis Engstrom Vice President Dec. 4, 2008 P 500 0 0 $0
Caleb Desrosiers Director June 23, 2026 A — 0 0 $0
Joy S. Goudie Director June 23, 2026 A — 0 0 $0
Henry D. Cremisi Director June 23, 2026 A — 0 0 $0
Edward Feuer Director June 23, 2026 A — 0 0 $0
Bernhard Saxe Director April 22, 2014 P 200 0 0 $0
Robert Willens Director May 9, 2013 P 18,164 0 0 $0
Philip Nordan Hudson Director March 28, 2012 P 146,200 0 0 $0
Martin S Wolpoff Director June 3, 2009 P 4,000 0 0 $0
Robert G Moussa Director Oct. 31, 2006 P 1,000 0 0 $0
Stephen Valentine Director Oct. 13, 2005 P 500 0 0 $0
James A Lombard Director Oct. 11, 2005 X 1,500 0 0 $0
Bruce Slovin — May 26, 2004 S 0 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VTI · VANGUARD INDEX FUNDS 0.00% 48,831 SH Aug. 8, 2026 Daily